Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
NEPHROS INC
| Metric | NEPHROS INC NEPHHealthcare |
|---|---|
| Quality Score | 82 / 100 |
| Revenue (latest) | $19M |
| Net income (latest) | $1M |
| Operating margin | 6.1% |
| Net margin | 6.4% |
| Return on equity | 11.7% |
| Return on assets | 8.8% |
| Return on capital (ROCE) | 10.5% |
| Debt / equity | 0.34× |
| Revenue growth (YoY) | 32.7% |
| Altman Z″ (distress) | -26.46 |
| Accruals / assets | −3.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.